OR WAIT null SECS
© 2022 MJH Life Sciences and Consultant Live. All rights reserved.
Johns Hopkins Medicine
September 30, 2021
Sophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger; and John J. Strouse, MD, PhD, share key takeaways and closing thoughts for the management of sickle cell disease.
September 23, 2021
Experts in hematology address unmet needs and precautions patients can take to avoid complications of sickle cell disease.
Drs Sophie M. Lanzkron, Jeffrey D. Lebensburger, and John J. Strouse, share insights on the safety profile and cost of gene therapy for the management of sickle cell disease.
September 16, 2021
Expert hematologists comment on the use of crizanlizumab in reducing painful crisis frequency in sickle cell disease and share their experience with the drug in clinical practice.